| Authors: |
Cherng HJ; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY., Alig SK; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Oki Y; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Nastoupil LJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Fayad L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Neelapu SS; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Turturro F; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hagemeister F; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Craig AFM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Macaulay CW; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Rodriguez MA; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., McDonnell TJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Flowers CR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Green MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Kurtz DM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Alizadeh AA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA., Davis RE; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Westin JR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. |
